OCT News and Research

RSS

Biden’s no-jab-no-job order creates quandary for nursing homes

President Joe Biden's edict that nursing homes must ensure their workers are vaccinated against covid-19 presents a challenge for an industry struggling to entice its lowest-paid workers to get shots without driving them to seek employment elsewhere.

20 Aug 2021

Study finds only 15% of rural health care workers have SARS-CoV-2 antibodies

Antibody testing of health care workers in three rural counties in eastern South Dakota and western Minnesota showed only 15% of the study participants had antibodies to the novel coronavirus.

4 Aug 2021

Olympic dream dashed after bike crash and nightmare medical bill over $200k

It was a race in Pennsylvania that could have sent cyclist Phil Gaimon to the Tokyo Olympics; instead, a serious crash landed the Californian in two hospitals on the East Coast.

29 Jul 2021

Wildfire smoke may greatly increase susceptibility to COVID-19

Wildfire smoke may greatly increase susceptibility to SARS-CoV-2, the virus that causes COVID-19, according to new research from the Center for Genomic Medicine at the Desert Research Institute (DRI), Washoe County Health District (WCHD), and Renown Health (Renown) in Reno, Nev.

16 Jul 2021

Study could guide future treatment of multisystem inflammatory syndrome in children

Children and adolescents with multisystem inflammatory syndrome in children (MIS-C) who are treated initially with intravenous immune globulin (IVIG) and glucocorticoids have reduced risk for serious short-term outcomes, including cardiovascular dysfunction, than those who receive an initial treatment of IVIG alone, a new study finds.

12 Jul 2021

Surprising similarities found in membrane proteins of bacteria and humans

The cells of simple organisms, such as bacteria, as well as human cells are surrounded by a membrane, which fulfills various tasks including protecting the cell from stress.

24 Jun 2021

Study focuses on retinal roughness in Alzheimer’s disease

Over recent years, the retina has established its position as one of the most promising biomarkers for the early diagnosis of Alzheimer's.

23 Jun 2021

Montana tribe welcomes back tourists after risky shutdown pays off

Millions of people will flock to Montana's Glacier National Park this summer after last year's pandemic-caused tourism skid, and they will once more be able sightsee and camp nearby on the recently reopened Blackfeet Indian Reservation.

21 Jun 2021

Study reveals risk factors associated with COVID-19 outcomes for people with IDD

A study of nearly 550 adults with intellectual and developmental disabilities receiving residential services in New York City found that age, larger residential settings, Down syndrome and chronic kidney disease were the most common risk factors for COVID-19 diagnosis, and heart disease was most associated with COVID-19 deaths.

14 Jun 2021

COVID-19 public health efforts linked to dramatic decline in COPD hospitalizations

Researchers at the University of Maryland School of Medicine analyzed data at the 13-hospital University of Maryland Medical System and found public health measures designed to reduce the spread of the COVID-19 virus may have fostered a substantial side benefit: Hospital admissions for chronic obstructive pulmonary disease (COPD) were reduced by 53 percent, according to a new study accepted for publication by a peer-reviewed medical journal and currently available at the online journal medRxiv.

14 Jun 2021

AI could predict treatment demand for chronic eye diseases

Age-related macular degeneration (AMD) is the most common cause of vision loss in people over 50. Up to 12 percent of those over 80 have the chronic disease.

8 Jun 2021

Study reports safety, efficacy of targeted treatment for IgA nephropathy

IgA nephropathy (IgAN) is a chronic kidney disease occurring in young adults and is one of the most common reasons for kidney transplantation in this age group.

7 Jun 2021

Redhill Biopharma announces completion of enrollment for oral opaganib phase 2/3 COVID-19 study

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that it has completed enrollment and randomized the last patient in the global Phase 2/3 study with opaganib (Yeliva, ABC294640) in patients hospitalized with severe COVID-19 pneumonia (NCT04467840).

7 Jun 2021

FDA seeks $6.5 billion for investments in core food safety, critical public health infrastructure

The U.S. Food and Drug Administration is requesting a total budget of $6.5 billion as part of the President's fiscal year (FY) 2022 budget - a nearly 8% ($477 million) increase over the agency's FY 2021 funding level for investments in critical public health infrastructure, core food safety and medical product safety programs and other vital public health programs.

29 May 2021

New technology makes it easier to diagnose neurodegenerative diseases

A new combination of optical coherence tomography (OCT), adaptive optics and deep neural networks should enable better diagnosis and monitoring for neuron-damaging eye and brain diseases like glaucoma.

25 May 2021

New approach could allow cardiologists to predict future heart attacks in high-risk patients

Analysing the forces at work behind the obstructions that cause heart attacks is crucial for identifying patients at risk of these events, says a study published today in eLife.

19 May 2021

Newly-developed respirator hood is a safe, effective personal protective equipment for COVID-19

Research by the University of Southampton and University Hospital Southampton has demonstrated that a newly-developed respirator hood is a safe form of personal protective equipment (PPE) for frontline healthcare workers and support staff.

15 May 2021

New technique can help to non-invasively assess progression of sickle cell retinopathy

Ophthalmologists at New York Eye and Ear Infirmary of Mount Sinai have created a new technique to evaluate patients with sickle cell retinopathy and assess the disease before it progresses and leads to permanent vision loss.

10 May 2021

Nanoscope presents optical gene delivery, OCT-guided electrophysiology platforms at ARVO annual meeting

Nanoscope Technologies LLC, a biotechnology company developing gene therapies for treatment of retinal diseases, is featuring multiple scientific presentations highlighting its groundbreaking research on optical gene delivery for vision restoration and OCT-guided electrophysiology platforms for characterization of retinal degeneration and assessment of efficacy of cell-gene therapy at the 2021 ARVO annual (virtual) meeting, May 1-7.

5 May 2021

Abbott’s new imaging platform powered by Ultreon 1.0 Software launches in Europe

Abbott today announced that its new imaging platform powered by Ultreon 1.0 Software, is now CE Marked in Europe.

30 Apr 2021